Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Somar

Biotech & Life Sciences · Mexico · Founded 2011 Thoroughbred

Pharmaceutical company in the health sector

Valuation
$0–100M
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

1 investor on Somar's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage
Envelp

Global footprint

Where Somar has talent and traffic

Workforce by country
3 countries with
team presence
🇲🇽 Mexico98.7%
🇧🇷 Brazil0.8%
🇺🇸 United States0.6%
3 countries shown
Web traffic by country
3.7K monthly visits
across markets
🇲🇽 Mexico100%
Top 1 markets shown

Market sentiment

What the market is saying about Somar

An AI-synthesized read of the highest-engagement posts about Somar on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Somar on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.